Ascendis Pharma A (ASND) Exchange Rate Effect (2014 - 2026)

Ascendis Pharma A has reported Exchange Rate Effect for 13 years, with the latest figure at $9.5 million in Q1 2026.

• Quarterly Exchange Rate Effect rose 204.89% year-over-year to $9.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (up 168.81% YoY) and the FY2025 annual result came in at -$29.4 million, down 220.75% from the prior year.
• Exchange Rate Effect grew to $9.5 million in Q1 2026 per ASND's latest filing, from -$570381.3 in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $9.5 million in Q1 2026 and troughed at -$9.0 million in Q1 2025.
• A 5-year average of -$200866.6 and a median of -$570381.3 in 2025 frame the typical range for Exchange Rate Effect.
• The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect plunged 9903.63% in 2025, then soared 204.89% in 2026.
• Over 5 years, Exchange Rate Effect stood at $2.3 million in 2022, then tumbled by 171.45% to -$1.6 million in 2023, then surged by 155.03% to $886934.2 in 2024, then tumbled by 164.31% to -$570381.3 in 2025, then soared by 1759.71% to $9.5 million in 2026.
• According to Business Quant data, Exchange Rate Effect over the past three periods registered $9.5 million, -$570381.3, and -$1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.